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Patients were cooled t013°-19°C. Using total circulatory arrest, the coarcted segment 
and associated aneurysm were resected followed by an interposition Hemashield graft. 
No crossclamps were used on the aorta. The mean circulatory arrest time was 26 min- 
utes (range 20-30 minutes). 
Results; There was no mortality, neurological morbidity or reoperetions for bleeding. 
There was one temporary recurrent laryngeal nerve neuropraxia. All patients had an 
uncomplicated recovery. The length of hospital stay ranged from 5-10 days. 
Concluelon; This technique for complicated adult coerctation is simple, safe end repro- 
ducible and allows anastomoses to be performed in a bloodless field with an excellent 
outcome. It is recommended for patients requiring reoperations on recurrent coarcta- 
tions, heavily diseased and calcified aortas where clamping the aorta is associated with a 
high risk of embolization and all adult coarctations where collateral circulation to the" spi- 
nal cord and viscera are in question. 
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866-1 Atrovastatin Improves an Atheroaclerotic and 
Proliferative Lesion on the Mitrel Valve Induced by 
Experimental  Hypercholesterolemla 
Nalini M. Rajamannan, Hani I. Salti, Raffay Khan, Robed H. Bonow, Sameer Gupta, 
Parag Jain, Nell Stone, Robert O. Bonow, Northwestern University Medical School, 
Chicago, I/linois. 
Background: Epidemiologic studies have linked degenerative mitral valve disease to risk 
factors for atherosclerosis. In this study, we charectedzed the pathology of the mitral 
valve in a hypercholesterolemic ( hol) rabbit model. Methods: 18 rabbits were assigned 
to 3 groups: normal diet, chol(t%) diet, and chol (1%) plus atorvastatin(2.5 mg/ 
kg)(Atorv). At 8 weeks, the mitral valves were harvested. Immunohistology of the mitral 
valves was performed using markers found in arterial atherosclsrotic lesions: anti-mac- 
rophage RAM-11, anti-alpha-actin, and anti- PCNA, DNA Polymerase Nuclear Antigen. 
Bone matrix expression was determined with anti-ostocpontin antibodies. A 5-point grad- 
ing system to describe the staining on the valves. (0-4 (high)). PCNA quantification was 
performed on all tissues with a computerized analysis system. (* p<;0.001 )Results:. All 
of the mitrel valves harvested from the chol-fed group were morphologically abnormal. 
Macrophage, alpha-actin, ostsopontin and PCNA were increased in the chol rabbits. Ator 
decreased the level of atherosclerosis, proliferation and bone matrix expression in these 
valves. Conclusion: Experimental hypercholesterolemia induces proliferation and 
osteopontin expression in the mitral valve that are typically seen in arterial atheroscle- 
rotic lesions. These changes may be modified with the use of a lipidolowering agent. 
These findings may provide a useful model to study the development of mitral valve dis- 
ease. 
Normal Cholesterol Cholestarot+ Atorvastatin 
Chol (mg/dl) 51 +/- 12 3235/-329 1943+/-17* 
RAM-11 0+/-0 1.83+/-1.5 0.27+/-0.06* 
alpha-actin 0.6+/-0.8 3.0+/-0.6 1.3+#0.97* 
ostaopontin + ++++ ++ 
PCNA 0+/-0 81 +/-17 22+/-10" 
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866-2 N-Terminal Brain Natrluretlc Peptlde Predicts 
Symptomatic Status and Severity of Mltrel 
Regurgitation In Patients With Mltral Regurgitation 
"Rmothv M. Sutton. Andrew J. Kerr, Ivor L. Gerber, Ralph A. Stewart, Teena West, Sally 
C. Greaves, Malcolm E. Legget, Tim G. Yandle, A. Mark Richards, Middlemora Hospital, 
Auckland, New Zealand, Graenlane Hospital, Auckland, New Zealand. 
Background: 
Timing of surgical intervention for mitral regurgitation (MR) is currently based on symp- 
tomatic status and echocardiogrephic parameters, with the aim of preserving left ventric- 
ular (LV) systolic function and prolonging survival. Identification of patients with severe 
MR and normal LV function whose ventricles are in the eerly stages of decompensation 
would enhance patient management and highlight hose who may benefit from surgical 
therapy. 
Our aim was to assess whether N-terminal brain natriuretic peptide (N-BNP) correlates 
with quantitative chocardiographic assessment of MR and symptomatic status. 
Methods: 
Consecutive patients (n-=34) with isolated mitral regurgitation and normal LV systolic 
function were identified. Patients with other potential causes for elevation of N-BNP were 
excluded. All patients underwent ransthoracic echo and N-BNP assay. Symptomatic sta- 
tus was assessed according to the NYHA classification. 
Results: 
N-BNP was higher in symptomatic than asymptomatic subjects: symptomatic (n=10, 
median 117pmol/I,IQR 54-175pmol/I) vs. asymptomatic (n=24 median 30pmol/I, IQR 20- 
62pmol/I) (p--0.O09) 
There was a moderate correlation between In(N-BNP) and left atnal size (r=0.64, 
p=0.0001), mitrel regurgitation score (r=0.54,p=0.0009), regurgitant fraction 
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(r=0.48,p--O.0009), vans contracta width (r=0.5,p=0.0009), left ventricular end systolic 
diameter index (r=0.47,p=0.0048) and left ventricular end diastolic diameter index 
(r=0.d7,p-~.0053) 
After adjusting for age and gender both higher In(N-BNP) (p=0.01) and severity of MR 
assessed by vena contracta width (p=0,01), regurgitant fraction (p=0.01) and MR score 
(p--0.O3) were associated with NYHA class. 
Conclusion: 
N-BNP increases with the severity of MR and with left ventdcular dimensions. Measure- 
ment of N-BNP may improve assessment of MR in the context of normal LV funCtion 
when clinical and/or echocardiographic data are inconsistent. 
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866-3 Chronic Persistent Efficacy of Basal Chordal Cutting to 
Relieve Ischemlc Mltral Regurgitation 
Emmanuel Messas, J. Luis Goerrero, Mark D. Handschumacher, Judy Hung, Noah Liel- 
Cohen, Suzanne Sullivan, Gus Vlahakes, Robert A. Levine, Massachusetts General 
Hospital, Harvard Medical School, Boston, Massachusetts. 
Mitral regurgitation (MR) conveys adverse prognosis in ischemic heart disease. Related 
to increased leaflet tethering by displaced attachments to the papillary muscles (PMs), it 
is incompletely treated by annular reduction. We therefore addressed the hvDothests that 
such MR can be reduced by cutting a limited number of critically positioned chordae to 
the leaflet base that most restrict closure but are not required to prevent prolapse. We 
compared two group of sheep: Group 1 (n=10) with chronic inferobasal infarcts known to 
give progressive MR and group 2 (n=5) with the same infarct site but with the two basal 
chordae cut st the time of the infarction. We analyzed 3D echo at infarct and chronic 
stage (8 weeks for group 1 and a mean of 33 weeks for group 2) for 3D valve geometry, 
LV volume and function, and MR stroke volume. Results: In Group 1, MR consistently 
increased over time as the LV remodeled (1.3 + 0.5 to 10.5 :t: 1.5 ml/baat, p < 0.01). In 
Group 2, no significant MR developed after a mean follow-up of 33 weeks (maximum, 43 
weeks) with no prolapse, flail, or significant post-infarct decline in LV function. Conclu- 
sion: Cutting a minimum number of basel chordae is persistently effective against 
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866-4 Timing of Mitrel Valve Closure- The Myth of the 
Isovolumlc Contraction 
Emmanuel Lansac, Khee Hiang Lira, Yu Shomura, Hou Sen Lim, Wolfgang Goetz, Scott 
Stevens, James H. Oury, Christophe Acar, Cados M. Duran, The Intemationa/Heart 
institute of Montana Foundation, Missoula, Montana, La Piti~ Salpetri~re Cardiac 
Surgery department, Paris, France. 
Background: Mitral valve closure is known to define end diastole. However the exact tim- 
ing of the mitral valve closure remains controversial. 
Methods: Twelve piezoelectric rystals (Sonomicrometry) were implanted in 7 sheep at: 
mitral annulus (tdgones T1-T2, transverse diameter P1-P2, antero posterior diameter 
AM-PM); free edge of anterior and posterior leaflet; tip of each papillary muscle (M1, M2); 
Left ventdcular endocardial wall opposite to the papillary tips (LVOT); apex of the left 
ventricle. The mitral valve was divided into 4 functional units: mitral annulus area; Ante- 
rior annulo-papillary apparatus (area between TI-T2-M1-M2); Posterior annulo-papillary 
apparatus (area between P1-P2-M1-M2); Papillary muscle area (area between M1-M2- 
LVOT). 
Results: The mitral valve was still open at end diastole since 57.2±4.3% (meen±SEM) of 
the closure occurred dudng the isovolumic contraction, Closure was only completed at 
the and of the isovolumic ontraction (gradient Aorte-LV=0). During this phase, the mitral 
valve movements were time related to LV pressure increase and corresponded to a com- 
plex deformation. All mitral valve levels underwent an early expansion followed by a con- 
traction during the second part of the isovolumic ontraction. This contraction had a wave 
progression starting in the left ventricle at the papillary muscle followed by the contraction 
of the anterior annulo-papillary apparatus (p= 0.00002) then the posterior annulo-papil- 
lary apparatus (p--0.022) and at last the mitral annulus contraction (p=0,084). Dudng sys- 
tole the inter-papillary muscle distance contracted the most (M1-M2: -25.2±1.9%) while 
the mitrel annulus area contracted by -16.1±1.9 %, However the length of the basal 
chords of the anterior leaflets (strut chord) remained almost constant (T1-M1 : -2.7±0.4%; 
T2-M2: -2.0±0.2%) whereas the distance between the posterior part of the mitrel annulus 
and the tip of the papillary muscle expanded (P1-M1: +6.0±0.8%; P2-M2: +9.0±1.4%), 
Conclusion: The mechanism of closure corresponded to a precise chronological defor- 
mation, The timing of mitral valve closure was surprising. These findings should question 
the definition of the isovolumic ontraction. 
